Osage University Partners — Pre-Seed & Seed VC Firm ($750K–$3.0M Checks)
Osage University Partners is a Pre-Seed, Seed venture capital firm based in Philadelphia, PA investing in Healthcare, AI / ML. The firm typically writes $750K–$3.0M checks and has 146 portfolio companies in our records.
- Check size
- $750K–$3.0M
- Portfolio
- 146 companies on record
- Partners
- 3 listed
- AUM
- $800M
- Stage
- Pre-Seed, Seed
- Sectors
- Healthcare, AI / ML
- HQ
- Philadelphia, PA
Last verified: 2026-05-24
Pre-Seed, Seed
$750K – $3.0M
$800M
146+ companies
3 partners
About Osage University Partners
Osage University Partners is a venture capital firm headquartered in Philadelphia, PA. The firm partners with university spinouts addressing transformative technology in biotech, healthcare, AI, and science-driven SaaS. Osage University Partners invests at the pre-seed and seed stages.
The firm focuses on the Life Sciences, Healthcare, and AI/ML sectors. Typical check size ranges from $750K to $3.0M. Osage University Partners has $800M in assets under management. Warm introductions are preferred.
Investment Thesis
Partners with university spinouts addressing transformative tech in biotech, healthcare, AI, and science-driven SaaS.
How Osage University Partners invests
Osage University Partners is a vc firm based in Philadelphia, PA. The firm invests at the Pre-Seed, Seed stages, with a focus on Healthcare, AI / ML.
Osage University Partners typically writes checks of $750K–$3.0M per investment, backed by approximately $800M in assets under management.
Osage University Partners has backed 146 companies in our records, including Karius, Inscopix, Aerie Pharmaceuticals.
Partners & Team
Marc Singer
Managing Partner
Shared perspectives on diligencing VCs, having multiple investors in a round, and red flags to look for in a potential VC partner.
Mitra Miri
Principal
Shared perspectives on diligencing VCs, having multiple investors in a round, and red flags to look for in a potential VC partner.
Industry Focus
Invests In
Investment Track Record
Osage University Partners has recorded investments in 146 portfolio companies. The firm has backed university spinouts including Aerie Pharmaceuticals, Aerovate Therapeutics, Agita Labs, AGTC, Algorithmia, Alphina Therapeutics, Ambiq Micro, Antiva Biosciences, Aptinyx, Arrakis Therapeutics, ArsenalBio, Artizan Biosciences, AssetWatch, Atsena, and Atsena Therapeutics.
Investments span Life Sciences, Healthcare, and AI/ML companies at early stages. The firm's team, including Bill Harrington as Senior Partner with focus on Life Sciences and AI, Marc Singer as Managing Partner with focus on Tech, and Mitra Miri as Principal with focus on Life Science, supports the investment approach.
Portfolio Companies (146)
Other
Karius
Inscopix
Aerie Pharmaceuticals
Aerovate Therapeutics
Agita Labs
AGTC
Algorithmia
Alphina Therapeutics
Ambiq Micro
Antiva Biosciences
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Healthcare, AI / ML — the sectors they actively back.
- •Size your ask to their typical $750K – $3.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Bill Harrington, Senior Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Osage University Partners is a match for your startup
Upload your pitch deck to see how well you match with Osage University Partners and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal